Who We Are
Toxsight is a biotechnology startup developing new platforms for rapid in vivo drug testing that accelerate drug development and fast screening drugs for emerging diseases. Our unique drug systems enable us to fast-track drug development and screening for personalized treatment.
Our rapid drug testing platform (RT-qMED) allows researchers to quickly and accurately measure a drug's efficacy and toxicity in preclinical studies. It enables early identification of promising compounds and reduces the cost and time associated with drug development. Furthermore, our platform is highly adaptable and can be used to study a wide range of diseases and compounds. We are committed to advancing treatments for patients and creating innovative solutions to further drug development.
